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Abstract 
MATRIX STIFFNESS REGULATES  
GLIAL CELL MORPHOLOGY AND DIFFERENTIATION 
By 
Mateusz M. Urbanski 
Advisor: Carmen Melendez-Vasquez 
Studies from our laboratory have shown that inhibition of non-muscle myosin II (NMII) 
activity has opposite effects on the formation of myelin by oligodendrocytes (OL), the myelinating 
glia of the central nervous system (CNS) and Schwann cells (SC), which perform the same function 
in the peripheral nervous system (PNS). The decrease of NMII activity in SC impairs their ability 
to establish polarity and myelinate, while its inhibition in OL enhances process branching and 
increases the amount of myelin formed in vitro an in vivo. A growing number of studies have 
shown that NMII also plays a role in the ability of cells to sense and respond to the stiffness of the 
surrounding extracellular matrix (ECM). In the PNS, the ECM consists of a dense SC-secreted 
basal lamina, which displays significantly higher rigidity than the more loosely organized CNS 
matrix.  
In order to evaluate whether the opposing effects of inhibiting NMII in glial cell 
differentiation and myelination are partly the result of NMII-mediated sensing of ECM stiffness, 
we have grown cultures of primary rat OL and SC on variable rigidity polyacrylamide matrices 
coated with covalently bound ECM proteins. We found that stiffer matrices inhibit OL branching 
as well as their expression of differentiation markers, and that these effects are correlated with 
iv 
increased NMII activity. SC also respond to changes in ECM stiffness, and those grown on rigid 
matrices adopt a more polygonal morphology with fewer actin-based protrusions than those grown 
on soft matrices. Interestingly, and unlike what we have observed in the OL, stimulation of SC 
differentiation after cAMP treatment is not affected by differences in matrix stiffness alone. 
However, SC differentiation is potentiated on rigid matrices at high laminin concentration, which 
are conditions that mimic a mature basal lamina. Taken together, our data indicate that myelinating 
glial cell differentiation is sensitive to changes in the mechanical properties of the ECM and that 
in the case of SC, these responses may be modulated by the maturity and composition of their 
basal lamina. 
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Chapter 1: Introduction 
Myelination 
Myelin is a specialized glial cell membrane, wrapped concentrically around axons of 
peripheral nervous system (PNS) neurons by Schwann cells (SC) and central nervous system 
(CNS) neurons by oligodendrocytes (OL). It is a concentrically laminated structure consisting of 
approximately 70% lipid and 30% protein, densely compacted as a result of the fusion of the inner 
leaflets of the plasma membrane and the extrusion of the cytoplasm.  
The compact myelin membrane has a vastly higher resistance and much lower capacitance 
than a simple lipid bilayer. These insulator-like properties are necessary for its best known 
function: allowing for the saltatory propagation of action potentials, which results in a 20-100 fold 
increase in the velocity of nerve conduction. While this aspect of myelin function was essential for 
the development of complex nervous systems in higher vertebrates, myelin also provides axons 
with crucial neuroprotection and metabolic support (Nave, 2010) (Fruhbeis et al., 2013) (Lopez-
Verrilli et al., 2013). 
Central and peripheral myelin are functionally equivalent in terms of insulating capacity 
and structurally similar, sharing the same polarized domains. Internodes consisting of compact 
myelin are interrupted by 1µm wide nodes of Ranvier, where voltage gated Na+ channels are 
clustered and action potentials are regenerated during saltatory conduction. Each node is flanked 
by specialized internodal regions: the paranode, in which junctional complexes of caspr and 
contactin anchor the paranodal glial loops to the axon, and farther in the juxtaparanode containing 
clusters of K+ channels (Salzer, 2003). The internodal membranes are compacted and organized 
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through the interaction of several major myelin proteins, such as proteolipid protein (PLP) and 
myelin basic protein (MBP) in the CNS, and myelin protein 0 (P0) and MBP in the PNS, as well 
as a number of less abundant ones (Nave and Werner, 2014).  However, despite the structural 
similarity of OL and SC myelin, the regulatory cues that control myelination and determine which 
axons are wrapped vary significantly between the CNS and the PNS.  
In the PNS, axonal diameter and the correlated expression levels of axonal neuregulin-1 
type III are major determinants of myelination, with larger axons myelinated and smaller ones 
ensheathed. The diameter of 1µm is the threshold above which myelination occurs, though ectopic 
expression of neuregulin-1 Type III can induce the myelination of normally unmyelinated fibers 
(Taveggia et al., 2005). Axonally derived signals such as neurotrophins, including nerve growth 
factor (NGF) and brain-derived neurotrophic factor (BDNF), are also capable of promoting SC 
differentiation and myelination (Chan et al., 2001; Chan et al., 2004).  In addition to axonal cues, 
extracellular matrix (ECM) signaling from the SC-secreted basal lamina (BL) also plays an 
important role in SC differentiation. GPR126, an adhesion G protein-coupled receptor (aGPCR), 
is among the most important mediators of this interaction. It binds to laminin ligands of the basal 
lamina, and is necessary for axonal sorting as well as capable of inducing a cAMP-mediated 
upregulation of key promyelinating SC genes such as Oct-6 and Krox20 (Mogha et al., 2013) 
(Petersen et al., 2015). Another target of abaxonal ECM signaling is focal adhesion kinase (FAK), 
which acts downstream of laminin binding by β1 integrins to promote SC spreading and radial 
sorting during the early stages of differentiation (Grove and Brophy, 2014). 
In the CNS, on the other hand, exogenous signals which are indispensable for initiating OL 
myelination have proven to be somewhat elusive. In fact, CNS myelination is to a large extent 
regulated by inhibitory signaling molecules, such as PSA-NCAM expressed by growing axons 
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(Charles et al., 2000), or the LRR and Ig domain-containing, Nogo receptor-interacting protein 
(LINGO1) expressed by neurons in response to the neurotrophin NGF (Lee et al., 2007).  In fact, 
in the absence of inhibitory cues, OL are capable of myelinating dead axons and plastic nanofibers 
(Lee et al., 2012). This certainly does not mean that there are no positive regulators of myelination, 
however.  For example, while ectopic expression of neuregulin-1 in normally unmyelinated axons 
such as those of superior cervical ganglia neurons is not enough to induce OPCs to myelinate them, 
mice heterozygous for neuregulin-1 do exhibit some hypomyelination (Taveggia et al., 2008), 
which implies that while neuregulin-1 is not sufficient and essential for OL myelination, it does 
promote it.  Similarly, while in contrast to the PNS the ECM of the adult CNS is very sparse and 
there is no traditional basal lamina except for that associated with the vasculature (Colognato and 
Tzvetanova, 2011), laminin expression has been detected in white matter tracts prior to 
myelination, and laminin-integrin signaling is capable of promoting oligodendrocyte precursor cell 
(OPC) survival (Colognato et al., 2002).  CNS laminin also contributes to OL differentiation: 
laminin- β1 integrin signaling promotes AKT-driven extension of myelin sheets and membrane 
wrapping (Barros et al., 2009), while laminin-dystroglycan interactions enhance process 
outgrowth of differentiating OL (Eyermann et al., 2012). Other, less immediately obvious cues 
also contribute: neuronal activity and synaptic vesicle release are able to enhance the myelination 
by nearby OL (Hines et al., 2015), while spatial constraints caused by increases in the density of 
OPC can increase the rate of OL differentiation (Rosenberg et al., 2008).  
The most striking difference between PNS and CNS myelination, however, has its basis in 
glial cell morphology. While in the CNS OL branch extensively and can often establish as many 
as 40 myelin segments in association with multiple axons, in the PNS each SC is in a one-to-one 
relationship with an axon, and produces only one solitary internode of myelin. The direct driving 
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force behind these vastly different phenotypes is the remodeling of the cytoskeleton, a process in 
which complexes of actin fibers and myosin motors play an essential role. Previous work from our 
laboratory indicates that one particular motor protein, non-muscle myosin II (NMII), is an 
important regulator of myelination. Inhibition of NMII promotes OL branching, differentiation 
and myelination (Rusielewicz et al., 2014; Wang et al., 2012; Wang et al., 2008) but impairs SC 
axonal sorting, differentiation and myelin formation (Leitman et al., 2011; Wang et al., 2008). 
Non-muscle myosin II 
Myosins are a family of motor proteins which generate force in an ATP-dependent manner, 
with the best known being the class II myosins responsible for skeletal, cardiac and smooth muscle 
contraction. The non-muscle class II myosins (NMII) perform a similar role, but on a much smaller 
scale – they interact with the actin cytoskeleton to regulate force generation and transmission at 
the cellular level. This makes them key players in maintaining cell shape and regulating 
morphology, cell migration, division, and many processes involving translating external forces 
into intracellular signals. Non-muscle myosins are present in all eukaryotic cells, and are 
hexameric molecules consisting of two 220 kD heavy chains (MHC), two 17 kD essential light 
chains, and two 20 kD regulatory light chains (MLC). NMII variants are differentiated by their 
heavy chains, and in mammals the MYH9, MYH10 and MYH14 genes encode the NMIIA, NMIIB 
and NMIIC isoforms (Conti and Adelstein (2008)). The MHCs consist of a globular head domain 
which contains both actin and ATP binding sites, a neck region to which the essential and 
regulatory MLC bind, and a long alpha-helical tail domain necessary for the formation of MHC 
homodimers, the tails of which can further interact with other NMII molecules to form bipolar 
filaments capable of cross-linking the actin cytoskeleton. Force generation by these filaments relies 
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on the ATPase activity of the MHC heads, which in turn depends on the phosphorylation of the 
regulatory MLCs on Ser19, with Thr18 phosphorylation serving to further enhance NMII activity 
(Hirata et al., 2009; Sellers et al., 1982).  The key players responsible for MLC phosphorylation 
status are the Ca2+/calmodulin dependent myosin light chain kinase (MLCK) and the Rho-
associated coil coil-containing kinase (ROCK), as well as the myosin phosphatase MYPT1. 
(Figure 1.1) MLCK and ROCK are both capable of phosphorylating the regulatory MLC on 
Ser19/Thr18, although ROCK has also been shown to negatively regulate MYPT1 activity (Feng 
et al., 1999). 
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Figure 1.1 Key regulators of NMII activity. 
Non-muscle myosin II activity is upregulated by the phosphorylation of its regulatory light chain 
(MLC). MLC phosphorylation is upregulated by the Ca2+/calmodulin dependent myosin light 
chain kinase (MLCK) as well as the Rho-associated coil coil-containing kinase (ROCK), and 
negatively regulated by myosin phosphatase MYPT1. Both MLCK and ROCK phosphorylate the 
regulatory MLC on Ser19/Thr18, but ROCK is also involved in the inhibition of MYPT1 activity 
(Sellers et al. 1982; Feng et al. 1999; Hirata et al. 2009). 
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Actin polymerization and NMII inhibition drive oligodendrocyte myelination 
Oligodendrocytes (OL) – the myelinating glia of the CNS – are derived from the ventricular 
zone and cortex of the embryonic mammalian brain (Kessaris et al., 2006). In the course of their 
development and in myelination, OL exhibit dramatic morphological changes. While they begin 
as bipolar, motile and mitotically active oligodendrocyte precursor cells (OPC) which respond to 
platelet-derived growth factor (PDGF) (Richardson et al., 1988), maturing OL extend a large 
number of increasingly complex processes culminating in wraps of myelin in vivo, or elaborate 
lamellar structures containing myelin proteins when cultured in the absence of axons in vitro. 
These proteins includes such maturation markers and myelin components as 2’,3’-cyclic 
nucleotide 3’-phosphodiesterase (CNPase) during earlier stages of differentiation (Reynolds and 
Wilkin, 1988), and proteolipid protein (PLP) and myelin basic protein (MBP) as they terminally 
differentiate (Monge et al., 1986). 
The morphological changes which occur during OL differentiation requires extensive 
remodeling of the actomyosin cytoskeleton, and therefore are largely driven by actin 
polymerization. Disrupting the mechanism of actin polymerization by the knockout of WAVE1, a 
key regulator of actin nucleation, results in impairment of OL process extension and branching, 
reduced expression of differentiation markers, and a significant reduction in myelin formation 
(Kim et al., 2006), indicating that morphological maturation precedes and promotes OL 
differentiation.  
Since NMII activity promotes the retraction of actin-based processes and inhibits the 
formation of lamellar structures, one might predict that NMII is a negative regulator of OL 
differentiation, and inhibition of NMII activity should promote myelination - and that is in fact 
what prior work from our laboratory (Figure 1.2) established. Initial in vitro studies performed in 
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cultures of OL alone and in co-cultures of OL and dorsal rat ganglion (DRG) neurons verified that 
a decrease in Myosin II activity is an inherent part of OL maturation, and showed that inhibition 
of Myosin II activity through small molecule inhibitors or siRNA leads to an increase in OL 
morphological complexity and increases the number of myelin segments produced in co-cultures 
(Wang et al., 2008). These effects were further confirmed by experiments in which over-
expression of myosin II or of a constitutively active form of its positive regulator RhoA led to a 
marked decrease in OL branching, while mouse OL in which myosin IIB had been knocked out 
displayed more rapid morphological maturation and higher levels of expression of one of the key 
myelin components, MBP (Wang et al., 2012). 
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Figure 1.2 Inhibition of myosin II enhances myelin formation and OLbranching. 
A. Myelinating OL-DRG cocultures, stained for MBP (green) and neurofilament (blue). Treatment 
with the myosin II inhibitor blebbistatin resulted in a prominent increase in the amount of myelin 
segments formed.  B. Quantitation of the number of myelin segments formed per single OL in 
cultures. A significant increase in the average number of myelin segments made by a single OL in 
treated cultures was observed (p<0.001, t-test). C. Analysis of OL branching was carried out in 
cultures kept for 3 days in differentiation promoting media in the absence or presence of 
blebbistatin. The mean fractal dimension (D), which correlates with the extent of cell arborization, 
was significantly higher in blebbistatin treated cultures (control 1.37 ± 0.12 vs. treated 1.46 ± 0.08; 
mean ± SD; p<0.0001; t-test), indicating a more complex cytoskeleton branching in the absence 
of myosin II activity (Wang et al., 2008). 
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Schwann cell myelination requires NMII activity and ECM cues 
Schwann cell precursors (SCP) originate within the neural crest, and migrate from it 
alongside developing nerves during intermediate stages of embryonic development. These SCPs 
give rise to immature Schwann cells, which associate with axons and either ensheath multiple 
small caliber axons or sort single large caliber axons for myelination (Reviewed in (Jessen and 
Mirsky, 2005)). The markers of Schwann cell differentiation into myelinating cells have been well 
characterized, and include the decrease in the levels of the negative regulator of myelination c-Jun 
(Parkinson et al., 2008), as well as an upregulation of positive regulatory transcription factors such 
as Oct-6 and Krox20 (Monuki et al., 1989; Parkinson et al., 2004). 
Unlike what we have observed in the CNS, where inhibition of NMII activity is enough to 
produce a very significant increase in myelination, SC differentiation is actually significantly 
impaired by downregulation of NMII or its regulators. Prior work from our laboratory (Figure 1.3) 
shows that inhibition of myosin II activity in myelinating co-cultures of SC and DRG neurons by 
MLC shRNA treatment results in highly abnormal SC morphology (Wang et al., 2008). Rather 
than sort individual axons, SC extend multiple long processes that often fail to contact axons. 
When there is axonal contact, the expression of N-Cadherin, which promotes initial SC alignment 
with axons (Wanner and Wood, 2002), is patchy and aberrant. This results in a significant 
reduction in the number of myelin segments produced. Likewise, while inhibition of the key NMII 
regulator MLCK initially results in a pattern of gene expression reminiscent of SC differentiation, 
these SC are incapable of myelination in a SC/DRG co-culture system. Interfering with this aspect 
of NMII regulatory machinery apparently decouples the initiation of the differentiation program 
from myelin assembly (Leitman et al., 2011).       
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SC differentiation and myelination is also a process which depends very heavily on ECM 
– in this case, the abaxonal SC-secreted basal lamina – and ECM adhesion molecules. For example,
genetic ablation in mice of the α2 subunit of laminin-211, which is a major basal lamina 
component, results in SC production of thin patchy myelin, and leads to skeletal muscle dystrophy 
in mice (Nakagawa et al., 2001). Similarly, disruption of laminin-411, which is also a BL 
component, leads to impaired radial sorting, reduced myelination, and ataxia. Comparable 
deficiencies can be observed in myelination by SC in which β1 integrin, a critical subunit of the 
laminin receptor α6β1, has been deleted (Feltri et al., 2002), demonstrating that signaling from the 
dense, ECM-rich BL is essential for normal SC myelination and axonal health.   
Figure 1.3 Knockdown of myosin II by shRNA results in abnormal SC morphology and 
inhibits myelination. 
A. Detail of a SC expressing shRNA targetting MLC (green) in coculture with axons (blue). The 
SC has multiple long processes, some of which appear to contact axons (asterisks), while others 
fail to do so (arrowheads). B. SC infected with a lentivirus expressing shRNA against the 
regulatory chain of myosin II (shMLC) or a scrambled non-targeting sequence (shSCR) were 
seeded onto purified dorsal root ganglion (DRG) neurons and allowed to myelinate. Cocultures 
were stained for MBP (red) and neurofilament (blue). A clear reduction in the amount of myelin 
formed in cocultures by SC expressing shMLC compared to those expressing non-targeting (SCR) 
shRNA was consistently observed. Right panel: Quantitation of MBP+ segments in 18 day 
myelinating cocultures infected with shMLC or non-targeting control (shSCR) (Wang et al., 2008). 
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NMII in mechanotransduction 
Differentiation and development are often thought of in terms of cells responding to 
chemical cues by the activation of signal transduction pathways culminating in the translation of 
target genes. The study of mechanotransduction expands on this view by demonstrating that 
physical forces acting on cells are also capable of regulating both cell morphology and gene 
expression, guiding differentiation and development.  
The most basic, and most intuitive example of mechanotransduction at work is the 
regulation of cell morphology by ECM elasticity. Most cells are surrounded by ECM, and 
connected to it by adhesive complexes tethered to the cytoskeleton. This means that any physical 
forces acting on the tissue and ECM are transmitted to the interior of individual cells – and in order 
to maintain its shape and resist deformation, a cell must regulate the contractile activity of its 
actomyosin cytoskeleton to match its elastic properties to those of the surrounding ECM 
(Reviewed in (Clark et al., 2007) and (Vicente-Manzanares et al., 2009)).  The process starts when 
integrins, which are localized in nascent adhesive complexes, are activated by their binding to 
ECM ligands and by the tension of the ECM. This in turn leads to stimulation of RhoA and ROCK 
signaling, which promotes myosin activity by regulatory MLC phosphorylation, and also 
contributes to actin polymerization. Ultimately, the increase in NMII contractility and actin 
polymerization cause conformational changes within the adhesive complex that lead to increased 
integrin clustering and activation, forming a feedback loop and generating a level of tension 
matching the ECM (Choquet et al., 1997). This plays an important role in cell adhesion, and the 
resulting polarization of the actomyosin cytoskeleton is also involved in durotaxis, or cell 
migration from soft to rigid ECM (Wang et al., 2001) (Raab et al., 2012). This phenomenon has 
great physiological relevance, due to its involvement in malignant transformation and metastasis: 
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increased ECM stiffness upregulates focal adhesion assembly and promotes tumor invasion, and 
does so in a Rho GTPase dependent manner (Parri and Chiarugi, 2010).      
Increased cytoskeletal tension in response to ECM engagement and rigidity also has 
particularly notable effects on the regulation of cell protrusion and branching and has been 
demonstrated repeatedly in endothelial tip cells (EC) (Fischer et al., 2009), cortical neurons 
(Georges et al., 2006) and mesenchymal stem cells (MSC) (Engler et al., 2006). Cells plated on 
soft ECM-like substrates extend larger numbers of more complex protrusions than those grown on 
rigid ones, and in EC and MSC the ability to respond to ECM stiffness was demonstrated to require 
NMII activity, with myosin contractility acting as a “brake” on the protrusion of actin-based 
processes and localized decreases in NMII activity often preceding the initiation of new branches 
(Fischer et al., 2009).    
However, mechanotransduction is not limited to exerting control over morphology and 
migration – it can also regulate transcriptional activity and direct the differentiation of 
uncommitted cells. Bodily tissues vary significantly in ECM composition, and it has emerged that 
seeding progenitors or stem cells on substrates matching the elastic properties of specific tissues 
can be used to direct the cells to activate transcriptional programs corresponding to that tissue type.  
For example, soft ECM-like matrices (0.1-1.0 kPa) are capable of directing mesenchymal stem 
cells to assume an adipocyte-like profile of gene expression, while more rigid ones (25-40 kPa) 
direct the cells toward and osteocyte-like fate. However, NMII inhibition and disruption of 
cytoskeletal tension abolishes these cellular responses to ECM rigidity (Engler et al., 2006), as 
does the disruption of the RhoA-based NMII regulatory machinery (McBeath et al., 2004). 
Although the exact mechanisms by which this cytoskeletal tension is transmitted to the nucleus is 
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not yet completely understood, the transcriptional cofactors YAP/TAZ as well as the components 
of the nuclear lamina appear to play a prominent role in the process. 
YAP/TAZ, perhaps best known for their role in the Hippo pathway and growth regulation, 
have recently emerged as mechanotransduction’s master regulators, translocating between the 
cytoplasm and the nucleus in response to mechanical cues. In mesenchymal stem cells (MSC) 
grown on soft 1 kPa matrices which resemble adipose tissue, YAP/TAZ localizes to the cytoplasm, 
and causes the MSC to develop into adipocytes. Conversely, on 40 kPa matrices resembling 
cartilage, YAP/TAZ translocates to the nucleus and causes the MSC to differentiate into 
osteoblasts (Dupont et al., 2011). YAP/TAZ knockdown is capable of directing cells grown on a 
rigid matrix to develop into adipocytes, while YAP/TAZ overexpression can overcome the effects 
of soft ECM, and direct MSC growing on it to develop into osteocytes. Notably, YAP/TAZ only 
translocates in response to variations in ECM stiffness if the contractile machinery of the cells is 
intact – inhibition of NMII or RhoA/ROCK activity renders cells unable to respond to changes in 
YAP/TAZ levels and localization. YAP/TAZ localization also appears to be regulated by PKA 
activity, in that PKA promotes the phosphorylation and cytoplasmic retention of YAP/TAZ (Yu 
et al., 2013) in a process that also involves downregulation of RhoA activity (Yu et al., 2012). (See 
Figure 1.4 for summary of YAP/TAZ NMI-mediated regulation.) Effectively, downregulation of 
either NMII or YAP/TAZ causes MSC to differentiate as if they were growing on a soft matrix or 
developing within a soft tissue.   
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Figure 1.4 RhoA-dependent mechanism of YAP/TAZ localization. 
Increased matrix stiffness promotes integrin engagement, RhoA/ROCK activity and actomyosin 
contractility, (Wada et al., 2011) leading to a nuclear localization of YAP/TAZ. YAP/TAZ direct 
the lineage specification of MSC, with cytoplasmic YAP/TAZ promoting adipogenesis, and 
nuclear YAP/TAZ osteogenesis (Dupont et al., 2011). YAP/TAZ localization is also regulated by 
phosphorylation via the LATS kinases, which are themselves negatively regulated by RhoA. 
Phosphorylated cytoplasmic YAP/TAZ is targeted for degradation in a PKA dependent process 
(Yu et al., 2013) that also leads to a downregulation of RhoA activity (Yu et al., 2012). 
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Another possible mechanism contributing to how signals are transduced to the nucleus 
involves the nuclear lamina. The nuclear lamina is the structural framework supporting the nuclear 
membrane, and its main components are the intermediate filament proteins lamin A and lamin B. 
Mutations in the lamin genes are associated with a wide range of pathologies, with lamin A being 
implicated in autosomal-dominant Emery-Dreifuss muscular dystrophy, dilated cardiomyopathy 
and Hutchinson-Gilford progeria syndrome, to name a few (Dechat et al., 2008). Interestingly, 
while there are far fewer diseases associated with lamin B defects, one of them is adult-onset 
autosomal dominant leukodystrophy, in which a duplication of the lamin B gene leads to fatal loss 
of myelin (Padiath et al., 2006) (Lin et al., 2014). As a support structure, the nuclear lamina 
maintains nuclear shape, anchors the nucleus to the actin cytoskeleton, and participates in the 
organization and localization of chromatin (Reviewed in (Puckelwartz et al., 2011)). The breaking 
of this linkage, as seen for example in dilated cardiomyopathy, leads to a disruption of the 
cytoskeleton, abnormal nuclear shape, and aberrant heterochromatin clumping (Nikolova et al., 
2004). 
 Recently, it was established that ECM rigidity, which translates into stiffness of the 
actomyosin cytoskeleton and NMII activity, is capable of regulating the expression and 
localization of nuclear lamins (Swift et al., 2013). These findings show that lamin A expression 
increases with tissue stiffness, while lamin B predominates in soft tissues such as the brain, and 
that changes in lamin A levels are capable of regulating MSC differentiation. Specifically, soft 
ECM which induces low levels of actomyosin contractility reduces the levels of lamin A and 
promotes MSC differentiation into adipocytes, while rigid ECM which upregulates cytoskeletal 
tension leads to an increase in lamin A levels and skews MSC differentiation toward osteogenesis. 
Furthermore, increases in lamin A levels within the nuclear envelope also appear to activate a 
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system of positive feedback by promoting serum response factor (SRF) activity, which in turn 
leads to increased actomyosin expression (Buxboim et al., 2014; Ho et al., 2013). (See Figure 1.5 
for overview of lamin A response to ECM rigidity.)   
In summary, ECM stiffness is capable of regulating NMII activity and the tension of the 
actomyosin cytoskeleton, which directly influences cell morphology and migration, and acts 
through secondary mediators such as YAP/TAZ and nuclear lamins to regulate the differentiation 
of uncommitted cells. In view of our previous work on myelination, this raises the question of 
whether the disparate impact of NMII activity on the morphology and differentiation of 
oligodendrocytes and Schwann cells is a reflection of the differences in the physical properties of 
the CNS and the PNS.  
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Figure 1.5 Regulation of nuclear lamin A levels in response to ECM stiffness. 
Increased tissue stiffness or matrix rigidity increases the nuclear levels of lamin A, a major 
structural component of the nuclear lamina, resulting in changes in chromatin organization and 
gene transcription (Swift et al., 2013).  Increased lamin A expression also promotes the activity of 
the serum response factor (SRF). This generates a feedback loop through increased expression of 
actomyosin cytoskeleton components including NMII, (Buxboim et al., 2014) leading to increased 
stress fiber formation and greater cytoskeletal tension (Ho et al., 2013). 
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ECM and tissue elasticity in disease and regeneration 
The mechanical properties of what are commonly called soft tissues vary widely, across 
multiple orders of magnitude (Reviewed in (Levental et al., 2007)), and have an acknowledged 
role in development (Wozniak and Chen, 2009). They have also been shown to influence various 
pathologies – changes in ECM composition contributes to the metastatic activity of many cancers 
(Pickup et al., 2014), while an increase in tissue stiffness correlates with the development of 
fibrosis in the liver (Georges et al., 2007) and lungs (Dolhnikoff et al., 1999). 
There is ample evidence that ECM composition and elasticity of CNS tissues are also 
affected by disease and injury, ranging from the increased tissue stiffness observed in chronic 
multiple sclerosis (Cedric Raine, personal communication) (Ludwin and Raine, 2008), to fibrosis 
caused by spinal cord injury (Soderblom et al., 2013) or stroke (Fernandez-Klett et al., 2013). In 
addition, it has been shown that in active multiple sclerosis lesions there is a marked increase in 
the deposition of laminin, collagen and heparin sulfate proteoglycans within the brain parenchyma 
(van Horssen et al., 2006), while in mouse models, ethidium bromide-induced demyelination 
results in increased expression of tenascin, fibronectin and vitronectin (Zhao et al., 2009). This 
suggests that the observed increase in stiffness can be a result of increased ECM deposition. 
However, while implantation of elastic substrates to promote optimal wound healing and minimize 
scar formation has been proposed (Khaing et al., 2014), and there are ongoing efforts to generate 
autologous neuronal and glial progenitors for transplantation, little work has been done to evaluate 
the effect of ECM stiffness and mechanosensing on CNS regeneration, especially in the context of 
myelinating glia rather than neurons.  
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Similarly, while there have been many attempts to generate implantable biomaterial 
scaffolds or engineered tissue grafts to promote peripheral nerve repair after injury (Daly et al., 
2013), and efforts to design engineered tissue grafts composed of extracellular matrix protein and 
SC have demonstrated that mechanical forces promote ECM reorganization conducive to nerve 
repair (Georgiou et al., 2013), the effect of the specific mechanical properties of these scaffolds on 
both axonal outgrowth and SC differentiation has not been examined. 
What role does matrix rigidity play in regulating glial cell differentiation? 
Mechanotransduction is the ability of cells to convert mechanical stimuli from their 
environment into biochemical signals. One common type of mechanotransduction involves the 
upregulation of cytoskeletal tension and NMII activity in response to increases in the rigidity of 
the ECM. This process has been shown to play a role in regulating the morphology of a wide range 
of cells, from fibroblasts to endothelial cells and neurons. It has also been implicated in controlling 
the morphology and lineage commitment of mesenchymal stem cells. 
The differentiation of myelinating glia is also dependent on NMII activity: inhibition of 
NMII enhances myelination in the CNS, and impairs it in the PNS, and both OL and SC respond 
strongly to modulation of NMII activity. We also know that the ECM of the brain is diffuse and 
highly viscoelastic, while that of the PNS, where SC are surrounded by a dense basal lamina 
containing large amounts of laminin and collagen, is much more rigid.  
We therefore hypothesize that ECM stiffness, sensed in a myosin II-dependent manner, 
plays a role in regulating glial cell morphology and differentiation (Figure 1.6) and propose to 
examine the hypothesis by testing the following: 
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a) Does the elasticity of the ECM affect the branching morphology of glial cells?
b) Is the branching of cells grown in a rigid ECM inhibited by myosin II activity?
c) Does variation in ECM elasticity affect the ability of glial cells to differentiate?
Figure 1.6 Proposed model of ECM regulation of glial morphology and differentiation. 
Low ECM stiffness in the CNS contributes to low levels of actomyosin contractility and promotes 
oligodendrocyte branching and differentiation. Conversely, the rigid ECM of the PNS promotes 
actomyosin activity, which is required for SC differentiation and myelination. 
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Chapter 2: Design and validation of an in vitro model of variable ECM rigidity 
In vitro models of ECM matrix stiffness allow for the study of developmentally relevant 
processes such as cell migration and differentiation without the many challenges and confounding 
factors present in an in vivo system.  For our work, we elected to use an approach using synthetic 
polyacrylamide (PA) substrates representing ECM of specific stiffness seeded with primary rodent 
oligodendrocytes and Schwann cells. While it is possible to fabricate gel substrates from purified 
ECM proteins or protein mixtures such as collagen, fibronectin or matrigel, PA substrates offer a 
number of important advantages. Their elastic modulus is simple to regulate by varying the relative 
concentration of polyacrylamide and bis-acrylamide, the ligand-binding capacity of PA does not 
vary significantly with changes in its mechanical properties, nonspecific binding to the PA surface 
is minimal, and it is a method which has been used extensively in the mechanotransduction field. 
The system uses glass cover slips coated with a thin (~50 µm) layer of polyacrylamide gel that is 
then modified by covalent attachment of ECM proteins. The resulting “sandwich gel”, described 
by (Tse and Engler, 2010) and (Fischer et al., 2009) provides a uniform surface suitable for cell 
culture, and reliably simulates an ECM of a given rigidity. (See Figure 2.1 and the materials and 
methods section for details of preparation.) 
The stiffness of ECM can be expressed in terms of elastic modulus or “E” values, which 
corresponds to force applied per unit area divided by the resulting change in length, measured in 
kilopascals (kPa). The values we selected for our substrates were ~ 1.5 kPa (“soft gels”) and ~ 30.0 
kPa (“rigid gels”), and were confirmed using atomic force microscopy (AFM). (Table 2.1) The 
values were chosen to fall within the range of those reported for normal rodent brain tissue (0.1-
1.6 kPa) and fibrotic scar tissue (30.0-40.0 kPa) (Raab et al., 2012; Tyler, 2012).  For our PNS 
model, due to a lack reliable published values for peripheral nerves, we elected to perform AFM 
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measurements of adult rodent sciatic nerves. Our data (Figure 2.2, Table 2.2) indicated a value 
range of 5 kPa (single teased nerves with intact basal lamina) to 50 kPa (intact nerve bundle 200 
µm in diameter), with intermediate-sized bundles falling in between these two extremes, while 
neonatal sciatic nerves for which we have gathered preliminary AFM data have stiffness values in 
the 6-12 kPa range. (data not shown) This allowed us to also use the ~1.5 kPa soft gels (well below 
the physiological range in the PNS) and ~30.0 kPa rigid gels (the average of the measured 
physiological range) for the SC experiments. We also independently confirmed that the published 
brain elasticity values matched those obtained using our method of AFM measurement. (Table 
2.2) 
In order to verify that apparent effects on cell differentiation were not due to changes in 
cell survival or proliferation, we evaluated cell death by ethidium homodimer-1 / calcein AM 
labeling, and cell proliferation index by Ki-67 staining. There was no apparent change in cell 
viability due to matrix elasticity for either OL or SC, with overall viability > 98%. The proliferation 
of OL was likewise not significantly affected, but the Ki-67 index of SC grown on rigid matrices, 
while not high, did show a statistically significant increase over those grown on soft matrices. 
(Figure 2.3) This effect of ECM rigidity on proliferation had been previously reported in other cell 
types (Mih et al., 2012), and does not represent a significant confounding factor during the 
relatively short time frame of our experiments.  
In summary, our in vitro model produces substrates which are highly reproducible in terms 
of their mechanical properties, closely models the range of elastic properties encountered in CNS 
and PNS tissues, and allows for culture and differentiation of primary glial cells with no adverse 
effects on cell survival. Chapter 3 describes our experimental results obtained through the use this 
system to culture and differentiate primary rodent oligodendrocytes and Schwann cells. 
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Figure 2.1. Preparation of ECM protein-coated polyacrylamide substrates. 
Polyacrylamide coated glass cover slips are covered with a cross-linker solution (sulfo-SANPAH) 
and irradiated for 5 minutes with 365nm UV light. The substrates are washed, then covered with 
a dilute solution of ECM protein and kept overnight in a tissue culture incubator. They are then 
extensively rinsed with PBS, and ready to be seeded with cells (Tse and Engler, 2010). 
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Figure 2.2 AFM force mapping of rodent sciatic nerve. 
AFM force maps of sciatic nerves embedded in elastic mounting medium. A. Large diameter 
non-dissociated nerves bundles composed of dozens of axons exhibit very high stiffness values. 
The areas of lower stiffness (20-30 kPa) visible in the lower left side of both panels represent 
mounting medium used to stabilize the tissue. B. Individual PNS nerve fibers surrounded by 
basal lamina are less stiff than intact nerves, but still several times more rigid than CNS tissue. 
C. Brightfield image showing the nerve segment analyzed in the top panel of section “B”, AFM 
probe visible on the lower left.   
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Figure 2.3 Proliferation of 
Schwann Cells (SC) and 
oligodendrocyte progenitors 
(OPC) on soft (1.5 kPa) and 
stiff (30.0 kPa) substrates. 
There was a modest but 
significant increase (Mann 
Whitney t-test, p<0.001) in SC 
proliferation in stiffer matrices 
compared to softer ones. 
While OPC cultures showed 
the same trend, the difference 
in proliferation was not 
statistically significant. (Mann 
Whitney t-test, p=0.06)  
Table 2.1  Measured elastic modulus of PA gels after polymerization. 
Acrylamide % Bis-Acrylamide % Ε ± SD (kPa) 
Soft Matrix 7.5 0.05 1.35 ± 0.09 
Rigid Matrix 12.0 0.28 33.15 ± 2.87 
Relative concentrations of acrylamide and bis-acrylamide for the soft and rigid PA gels used in 
these studies and their elasticity modulus as measured by AFM. Four PA hydrogels per condition 
and 768 indentations per hydrogel (256 indentations in 3 separate 90x90 µm areas per gel) were 
assessed for these measurements.     
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Table 2.2  Measured elastic modulus of mouse brain and sciatic nerve. 
E ± SD (kPa) 
  Cortex & White Matter 1.9 ± 0.9 
  Teased fiber (15 µm) 5.3 ± 0.9 
Intact bundle (200 µm) 49.4 ± 19.0 
Elastic modulus values obtained from fresh adult mouse sciatic nerves (10 mm long) and fresh 
coronal adult mouse brain slices. After removal of the surrounding fat and connective tissue, the 
elasticity of exposed intact nerve bundles and tissue slices was determined using AFM nano-
indentation.  
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Chapter 3: Myelinating glial differentiation is regulated by extracellular matrix elasticity 
Rigid ECM inhibits OPC branching complexity 
During oligodendrocyte differentiation in vitro OL extend increasingly complex branches 
in a process dependent on actin polymerization, which eventually fuse into elaborate lamellar 
sheets. In order to determine whether this is a mechanosensitive process which responds to ECM 
elasticity, we seeded rat OPCs on soft (~1.5 kPa) and rigid (~30.0 kPa) PA/matrigel substrates, 
chosen to correspond to the viscoelasticity of the normal brain and that of fibrous scar tissue, 
respectively.  The cells were grown in conditions promoting proliferation (10ng/mL PDGF/bFGF) 
for 48 hours, followed by fixation and visualization of the actin cytoskeleton by 
immunofluorescence. Proliferating OPCs grown on soft 1.5 kPa matrices displayed a marked 
increase in branching compared to those grown on rigid 30.0 kPa ECM. (Figure 3.1 A)  
Quantification of the morphological differences showed that on soft ECM, the percentage of cells 
exhibiting complex morphology (represented as Type II and Type III cells) was significantly 
higher than on the rigid matrix (51%±6 vs 44%±6 of Type II; mean±SEM, p=0.003; 28% ±3 vs 
22%±3 of Type III; mean±SEM, p=0.02). Conversely, the rigid 30.0 kPa matrix significantly 
increased the percentage of cells of low complexity (Type I) in comparison with the 1.5 kPa 
substrate (24%±3 vs. 14%±2; mean±SEM, p<0.001). (Figure 3.1 B)  This demonstrates that soft 
matrices with viscoelasticity comparable to the normal brain promote OPC branching, while rigid 
ones significantly inhibit it.  Furthermore, the inhibitory effect of stiff matrices on OPC branching 
was removed by treatment with the ROCK kinase inhibitor Y-27632 (Figure 3.2 A-B), which is 
consistent with previous reports that Rho/ROCK signaling and myosin II activity are involved in 
controlling OL branching (Liang et al., 2004), (Wang et al., 2012), as well as with the established 
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importance of Rho/ROCK activity for mechanosensing (McBeath et al., 2004). This was further 
confirmed by the observation that OPC purified from PlpCre/ESR1:Rosa26-mT/mG:NMII fl/fl 
and PlpCre/ESR1:Rosa26-mT/mG:NMIIB+/+ in which MIIB was conditionally ablated in 
oligodendrocytes (Rusielewicz et al., 2014) and grown on rigid matrices displayed increased 
branching complexity when compared to OPC from control animals. (Figure 3.2 C) 
Figure 3.1 Rigid ECM inhibits OPC branching complexity. 
A. OPC cultured for 48 hrs in proliferation-promoting medium display a significant decrease in 
branching complexity when grown on rigid substrates (right panel) compared to those grown in 
soft brain-like matrices (left panel). B. Quantitation of OL branching complexity. Cultures grown 
on the stiff matrix (30 kPa) display a large increase in the number of cells of low complexity 
(p<0.001, t-test) and a significant decrease in the number of high-complexity cells. (Type 2: 
p=0.003, t-test; Type 3: p=0.02, t-test). Data represent mean±SEM, approximately 1000 cells from 
two independent experiments were analyzed per condition. (Scale bars 25 µm.) 
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Figure 3.2 NMII inhibition rescues OPC branching on rigid ECM. 
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Figure 3.2 NMII inhibition rescues OPC branching on rigid ECM. 
A. In OPC cultured for 48 hrs in proliferation-promoting medium, inhibition of NMII activity with 
the Y-27632 ROCK inhibitor results in the rescue of OPC branching in cultures grown on rigid 
substrates (bottom panel). B. Quantitation of OL branching complexity. Cultures grown on the 
stiff matrix in the presence of Y-27632 exhibit a number of high complexity cells comparable to 
cultures grown on the soft, brain like matrices. Data represent mean±SEM, approximately 1000 
cells from two independent experiments were analyzed per condition. C. Ablation of NMIIB 
rescues OPC branching in stiff matrices. OPC derived from NMIIB conditional knockout mice 
(KO) exhibited increased branching when grown on rigid matrix compared to cells derived from 
wild type (WT). (Scale bars 25 µm.)   
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Rigid ECM inhibits T3-induced OPC maturation 
To examine whether the effects of matrix stiffness extend beyond regulation of OPC 
branching morphology, OPC were cultured on either soft 1.5 kPa or rigid 30.0 kPa substrates for 
48 hours in the presence of 30 ng/mL thyroid hormone (T3).  Similar to what we observed in 
proliferating cells, OPC branching complexity was significantly inhibited by rigid matrices. 
(Figure 3.3 A) Quantitation analysis of the T3 treated cultures indicated that on 30 kPa matrices, 
the percentage of low-complexity cells (Type I) increased significantly (12% ±2.6 vs. 4% ±2; 
mean±SEM, p<0.001) in comparison to the cultures grown on the less rigid matrices, while the 
percentage of high complexity cells (Type III) was decreased (55%±3.4 vs. 67%±3.5; mean±SEM, 
p=0.04) (Figure 3.3 B)  Additionally, we also observed an effect on OPC expression of maturation 
markers, as cells grown on the rigid 30.0 kPa matrix exhibited a significant decrease in the levels 
of Rip/CNPase and MBP (Figure 3.3 A,D) when compared to those cultured on the soft 1.5 kPa 
matrix. (Rip: 13% ± 1.9 vs. 25% ± 1.7; MBP: 4% ± 0.4 vs. 8% ± 0.5; mean ± SEM, p<0.001)  
These effects on OPC differentiation were accompanied by increased expression of pMLC and 
therefore higher NMII activity in the 30.0 kPa condition (Figure 3.3 C), which is consistent with 
prior work showing that NMII inhibition has the opposite effects and promotes both branching and 
MBP expression (Wang et al., 2012). 
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Figure 3.3 Rigid ECM inhibits T3-induced maturation of OPC. 
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Figure 3.3 Rigid ECM inhibits T3-induced maturation of OPC. 
A. OPC cultured on rigid substrates and treated with differentiation-promoting medium (T3) for 
48 hours display a decrease in branching complexity and the levels of maturation markers 
Rip/CNPase and MBP. B. Quantitation of branching complexity. Differentiating cultures grown 
on the stiff matrix display a significant increase in the number of cells of low complexity 
(p<0.0001, t-test) and a decrease in the number of high-complexity cells. (p=0.04, t-test) Data 
represent mean±SEM, approximately 1000 cells from two independent experiments were analyzed 
per condition. C. Increased phosphorylation of the regulatory myosin light chain (pMLC2) was 
detected in OL grown in stiffer matrices, indicating higher NMII activity. D. Cultures grown on 
the stiff matrix exhibit a highly significant (p<0.001, t-test) decrease in the number Rip/CNPase+ 
and MBP+ cells per field. (Scale bars 25 µm.) 
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OL grown on rigid ECM display higher levels of nuclear Olig1 
In the early stages of OL differentiation, the basic helix-loop-helix transcription factor 
Olig1 localizes to the nucleus and drives the expression of myelin genes, such as MBP (Li et al., 
2007). However, as the OL differentiation progresses, a significant fraction of Olig1 is 
phosphorylated and translocates from the nucleus into the cytoplasm, (Figure 3.4 A) which is 
necessary for the expansion of MBP-positive membrane during OL maturation (Niu et al., 2012). 
Since the effects of cytoplasmic translocation of Olig1 parallel those of a reduction in NMII 
activity or the OL morphological response to being cultured on soft ECM, we investigated whether 
Olig1 localization is dependent on the mechanical properties of the ECM, as that would provide a 
link between mechanical forces acting on the OL and the regulation of myelin gene expression.    
In order to evaluate Olig1 translocation in response to mechanical cues, we first seeded 
OPC onto 1.5 kPa and 30.0 kPa matrices under proliferating conditions, and found that after 48hrs 
in culture, the level of nuclear Olig1 as visualized by IF was significantly increased in cells grown 
on the 30.0 kPa matrix. (Figure 3.4 B-C) To determine whether this was also a factor during OL 
differentiation, we then biochemically assayed the levels of Olig1 in OPC cultured for 48hrs in a 
T3-containing medium. While overall expression of Olig1 did not change, nuclear levels of Olig1 
were nearly 90% higher (Figure 3.4 D-E) in cells grown on the 30.0 kPa matrices than they were 
in cells in the 1.5 kPa condition. This was accompanied by an increase in pMLC in cells grown on 
the more rigid ECM. (Figure 3.4 D-E) Since the key Olig1 residue necessary for its translocation 
to the cytoplasm is located within a well-conserved predicted PKA phosphorylation site, we also 
examined the levels of phosphorylated PKA substrates, and found that PKA phosphorylation of 
substrates matching the molecular weight of Olig1 increased in OPC grown on soft 1.5 kPa 
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substrates in comparison to the 30.0 kPa ones (Figure 3.4 D-E), which is consistent with the 
mechanism of Olig1 translocation described by (Niu et al., 2012). 
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Figure 3.4 Rigid ECM promotes nuclear retention of Olig1. 
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Figure 3.4 Rigid ECM promotes nuclear retention of Olig1. 
A. Representative images from OPC cultures showing a decrease in nuclear Olig1 and its increased 
cytoplasmic localization as they progress toward a more mature phenotype. B-C. OPC grown on 
stiffer matrices under proliferative conditions for 48 hrs display a highly significant increase in 
nuclear Olig1 levels (p<0.0001). Data represent mean±SEM, approximately 1000 cells from two 
independent experiments were analyzed per condition. D-E. In OPC grown under differentiation-
promoting conditions for 48 hrs, increased matrix stiffness promotes higher levels of 
phosphorylated regulatory myosin light chain (MLC2) and phosphorylated PKA substrates, as well 
as elevated levels of nuclear Olig1. (3 experiments) (Scale bars 25 µm.) 
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OL differentiating on rigid ECM exhibit elevated nuclear YAP/TAZ and nuclear lamin A 
The transcriptional coactivators YAP/TAZ have been shown to play a key role in 
transmitting mechanical signals to the nucleus and regulating differentiation in response to matrix 
elasticity.  Rigid ECM promotes the differentiation of MSC into osteocytes which is accompanied 
by nuclear YAP/TAZ localization, while soft ECM drives adipogenesis (Dupont et al., 2011) and 
causes YAP/TAZ to accumulate in the cytoplasm, where it can be targeted for inhibitory 
phosphorylation and degradation (Yu et al., 2013). Stiffness-dependent differentiation can also be 
modulated by the composition of the nuclear lamina - nuclear lamin A predominates in rigid tissues 
and organs, while lamin B levels are elevated in soft tissues (Swift et al., 2013), with the ratio of 
lamin A/B increasing with ECM rigidity.     
We found that in OPC cultured under differentiation-promoting conditions, nuclear levels 
of YAP were highly elevated in response to increased matrix rigidity, while differentiating OPC 
cultured on stiff matrices also exhibited an increased lamin A/B ratio (Figure 3.5 A-B), 
demonstrating that matrix stiffness is capable of regulating OL expression of these effectors of 
mechanotransduction. 
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Figure 3.5 Rigid ECM increases nuclear levels of YAP and Lamin A. 
A-B. In OPC grown in differentiation-promoting medium for 48 hrs, stiff matrix promotes 
increased levels of YAP and lamin type A in the nucleus, while decreasing the levels of lamin type 
B. (2 experiments) 
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Soft ECM promotes the formation and elongation of SC membrane protrusions 
The next question we examined was whether SC, like OL, are capable of responding to 
mechanical cues. Primary rat SC were seeded onto 1.5 kPa and 30.0 kPa substrates and cultured 
for 48 hours with or without the presence of cAMP as an inducer of differentiation.  Absent cAMP, 
SC on the soft substrates were more elongated, and displayed higher numbers of actin-rich 
processes along the membrane, while SC on the rigid substrates were more planar and had greater 
numbers of stress fibers. (Figure 3.6 A) Following treatment with cAMP, differences in 
morphology diminished with all cells assuming a more flattened morphology with fewer processes. 
(Figure 3.6 A) 
In order to quantitate the complex changes in SC morphology, we employed measurements 
of aspect ratio, which corresponds to cell elongation, and solidity, which is a measurement of cell 
branching (Carpenter et al., 2006).  For example, a stereotypical neuronal cell with many processes 
and one long axon would have a very high aspect ratio and low solidity, while a typical fibroblast 
would have a very low aspect ratio and high solidity.  In the absence of cAMP, SC grown on soft 
matrices have a significantly higher aspect ratio and lower solidity than those grown on rigid 
matrices, and the difference in aspect ratio persists after the initiation of differentiation by cAMP 
treatment. (Figure 3.6 B-C)  This demonstrates that SC are capable of responding to differences in 
matrix properties by regulating their morphology, and that their response to a decrease in matrix 
tension – increased process extension – is consistent with the effects we previously observed in 
SC as a result of NMII inhibition. 
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Figure 3.6 Soft ECM promotes Schwann cell elongation and formation of membrane 
protrusions. 
42 
High AR
Low Solidity
Low AR
High Solidity
A 1.5 kPa 30.0 kPa
P
h
a
ll
o
id
in
/D
A
P
I
B
-c
A
M
P
+
c
A
M
P
C SolidityAspect Ratio
Aspect Ratio
Solidity
1.00.45
2.0 1.0
Figure 3.6 Soft ECM promotes Schwann cell elongation and formation of membrane 
protrusions. 
A. SC morphological changes in response to ECM stiffness. Undifferentiated SC grown on soft 
substrates showed greater elongation and process extension, while those grown on rigid substrates 
displayed a more polygonal morphology. While cAMP treatment induced cell spreading and 
process retraction, differentiating SC grown on soft matrices still displayed greater elongation. 
Approximately 400 cells were analyzed per condition (2 coverslips / 100 cells per coverslip / 
duplicate experiments) B. Examples of aspect ratio measurement (Derived from the length and 
width of a best-fit ellipse based on the shape measured) and solidity (the area of the shape being 
measured divided by the area of the convex hull necessary to enclose it) and representative cells. 
C. Quantitation of changes in SC morphology. Undifferentiated SC grown on soft matrices 
exhibited a significantly higher aspect ratio and lower solidity than those grown on rigid substrates, 
while cAMP treated cells grown on softer matrices displayed greater elongation. (p<0.001). (Scale 
bars 25 µm.) 
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Soft ECM increases SC expression of c-Jun, but does not overcome the effects of cAMP 
induced differentiation 
Since ECM rigidity appeared able to influence SC morphology, we next investigated 
whether it was also capable of controlling SC differentiation. As before, SC were plated onto 1.5 
kPa and 30.0 kPa matrices and cultured with or without cAMP treatment over a period of 48-72 
hours. We found that in cells grown without cAMP, soft matrix produced a modest but statistically 
significant increase in the levels of the negative regulator of SC differentiation c-Jun (Figure 3.7 
A-B), but the levels of the positive regulators Oct-6 and Krox 20 were not affected (Figure 3.7 A-
D). Treatment with cAMP, which promotes SC differentiation (Morgan et al., 1991), lead to 
downregulation of c-Jun expression (Figure 3.7 A-B) and upregulation of Oct-6 (Figure 3.7 A-B) 
as well as  Krox20 (Figure 3.7 C-D) levels in cells grown on both types of matrix. While the 
increases in Oct-6 and Krox20 were slightly greater in cells grown on the 30.0 kPa matrices, the 
effects on Oct-6 were slight, and the elevation of Krox20 levels was not statistically significant. 
Additionally, while we observed that pMLC and pFAK levels were initially elevated in 
undifferentiated SC grown on the rigid matrices, cAMP treatment abolished the differential. This 
suggests that in this culture system, forces transmitted from the ECM and actomyosin contractility 
do not have a strong effect on cAMP-induced SC differentiation. 
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Figure 3.7 Soft ECM promotes SC expression of c-Jun but cAMP-induced differentiation is 
not significantly affected by matrix stiffness alone. 
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Figure 3.7 Soft ECM promotes SC expression of c-Jun but cAMP-induced differentiation is 
not significantly affected by matrix stiffness alone. 
A-B. Undifferentiated SC (-cAMP) growing on soft substrates showed a modest but significant 
increase in c-Jun expression (p<0.05). Addition of cAMP (+cAMP) abolished the differences in 
cell morphology and down-regulated c-Jun expression to comparable levels in both soft and stiff 
matrices. Upregulation of Oct6 expression after cAMP treatment was also observed in both 
conditions, although it was slightly higher in the stiff matrices. Approximately 400 cells were 
analyzed per condition (2 coverslips / 100 cells per coverslip / duplicate experiments) C-D. 
Increased phosphorylation of the regulatory myosin light chain (pMLC2) and FAK (pFAK) were 
detected in undifferentiated SC plated on stiffer matrices, indicating NMII activity and cell tension. 
These differences were abolished after addition of cAMP. Increased Krox-20 expression was 
observed in both matrices after cAMP treatment. (Scale bars 30 µm.) 
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Laminin potentiates the effects of stiff ECM on cAMP-induced SC differentiation 
While ECM mechanical properties alone are not sufficient to regulate SC differentiation, 
it is well established that ECM components such as laminins are necessary for normal SC radial 
sorting and myelination (Nakagawa et al., 2001; Wallquist et al., 2005). One receptor recently 
identified as essential for SC radial sorting and myelination is GPR126, an adhesion G-protein 
coupled receptor that interacts with laminin-211 (Petersen et al., 2015), and which may be 
responsive to the mechanical properties of the ECM (Liebscher et al., 2014) (Petersen et al., 2015). 
In order to examine whether the developmental status of the basal lamina may modulate 
the SC response to ECM rigidity and cAMP upregulation, we cultured SC on 1.5 kPa and 30.0 kPa 
matrices that were treated with collagen I and either 5 µg/mL or 20 µg/mL of mouse laminin, 
simulating the composition of either the immature or fully developed basal lamina (Grove and 
Brophy, 2014). Our data indicate that upon cAMP treatment the expression of Krox20 by cells 
grown on laminin-coated substrates was significantly increased in the 30.0 kPa condition, and that 
it was further enhanced by increased levels of laminin. (Figure 3.8 A-B)  This indicates that while 
SC differentiation can be upregulated by increasing ECM rigidity, this response is laminin-
dependent and may be influenced by the maturity of the basal lamina.  
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Figure 3.8 Increased laminin concentration potentiates SC differentiation on stiff ECM. 
A. Representative images from cultures of differentiating SC showing the effect of matrix stiffness 
and laminin concentration on the expression of Krox20. B. Quantitation of Krox 20 nuclear 
fluorescence. Krox20 expression and percentage of Krox20 positive cells were upregulated in SC 
grown on stiff laminin-coated matrices, with highest response observed at the highest laminin 
concentration. (p<0.001, 2 experiments) (Scale bars 20 µm.) 
48 
A
B
P
h
a
ll
o
id
in
/D
A
P
I
K
ro
x
2
0
1.5 kPa +cAMP
5 µg/mL 20 µg/mL
30.0 kPa +cAMP
5 µg/mL 20 µg/mLLaminin:
****
cAMP cAMP
Chapter 4: Discussion 
ECM dysfunction in CNS pathologies 
Pathological changes have been shown to influence the composition and mechanical 
properties of the ECM in various tissues. For example, development of rat liver fibrosis correlates 
with an increase in tissue stiffness (Georges et al., 2007) and similar changes are observed in the 
fibrotic lung (Dolhnikoff et al., 1999).  In the CNS, the effect of injury and disease on mechanical 
tissue properties has not been studied as extensively, since most work has focused on chemical 
cues produced in response to injury (Galtrey and Fawcett, 2007), the effects of which on regrowth 
and remyelination are by now well established (Levine et al., 2001; Silver and Miller, 2004; Yiu 
and He, 2006).   
However, there does exist a growing body of work indicating that ECM mechanical 
properties do play a role in CNS regeneration and remyelination. One of the key responses to CNS 
injury is astrocyte activation and the formation of the astrocytic scar, which contains the damage 
but may present a physical barrier to nerve repair and remyelination (Georges et al., 2006). The 
effects of this can be seen in multiple sclerosis (MS), where in acute lesions, myelination is more 
widespread before scar formation (Ludwin and Raine, 2008), while in chronic MS lesions that are 
notably more rigid than the healthy brain (Cedric Raine, personal communication), myelin repair 
is limited to a narrow area at the lesion margin that is in contact with healthy tissue (Prineas and 
Connell, 1978). Moreover, there is evidence that astrocytic activation itself is enhanced by 
increases in ECM rigidity (Janmey and Miller, 2011). The effects of these changes in ECM 
composition on OL regulatory pathways are largely unexamined, but recent work (Furusho et al., 
2015) demonstrates that FGF signaling is dispensable for remyelination in acute cuprizone-
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induced lesions but necessary in chronic ones, adding support to the idea that changes in the 
physical microenvironment can substantially regulate OL remyelination.  
CNS scarring that increases ECM density is also present in other pathologies: fibrosis 
occurs as a consequence of proliferation of stromal cells following stroke (Fernandez-Klett et al., 
2013), as well as due to perivascular fibroblast infiltration in spinal cord injuries (Soderblom et 
al., 2013), leading to the formation of a dense, ECM protein-rich core surrounded by reactive glial 
cells. Given this range of pathologies which dysregulate the ECM of the CNS, and the generally 
poor prospects for regeneration and repair following CNS injury, it is important to consider all 
possible factors that may influence recovery, including the impact of mechanical forces on the 
differentiation of and myelination by CNS glia. 
ECM mechanical properties regulate OL differentiation 
Process extension by OL is necessary for their morphological maturation as they establish 
contact with multiple axons, and strongly correlates with their differentiation and expression of 
myelin proteins. Previous work from our lab has shown that these processes are regulated by non-
muscle myosin II, and that higher levels of NMII activity decrease OL branching, expression of 
myelin proteins, and the number of myelin segments produced in vitro (Wang et al., 2012; Wang 
et al., 2008).  Conversely, in a mouse model in which demyelinating lesions of the corpus callosum 
were induced with lysolecithin, inhibition of NMIIB activity in the oligodendrocyte lineage 
significantly accelerated the rate of lesion repair and remyelination (Rusielewicz et al., 2014), 
demonstrating that NMII is a negative regulator of CNS myelination. 
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Mechanotransduction is also NMII dependent. Since NMII activity increases in proportion 
to ECM rigidity, and a number of CNS pathologies result in both glial and fibrotic scarring as well 
as increased ECM deposition, we investigated whether OL maturation and differentiation are 
affected by changes in the mechanical properties of the ECM. We found that increases in ECM 
stiffness result in a significant reduction of OL branching, and that this was accompanied by 
elevated levels of the phosphorylated NMII light chain, leading to an increase in NMII activity. 
This was consistent with the findings of (Wang et al., 2008) as well as with similar observations 
performed on endothelial tip cells by (Fischer et al., 2009). These effects of rigid (30.0 kPa) ECM 
were abrogated by treatment with Y-27632, an inhibitor of ROCK, or by the genetic ablation of 
NMII, providing evidence that OL mechanotransduction is a process dependent on NMII activity. 
In addition to its impact on OL morphological maturation, we also found that an increase in ECM 
rigidity has an inhibitory effect on key OL maturation markers, such as CNPase/Rip and MBP, 
demonstrating that ECM properties are also capable of regulating OL differentiation. In light of 
the findings from our laboratory that a reduction in cytoskeletal tension resulting from NMII 
ablation can significantly enhance the recovery from an acute demyelinated lesion (Rusielewicz et 
al., 2014), this suggests that NMII inhibition could also be used to promote myelin repair in chronic 
or fibrotic lesions featuring increased ECM stiffness. 
Interestingly, recently published studies show that while the ability of OL to extend 
processes and ensheath axons depends on actin polymerization and Arp 2/3 activity, myelin 
wrapping itself appears to require actin disassembly, with movement of the inner tongue of the OL 
myelin membrane driven by alternating cycles of actin polymerization and depolarization, 
dependent on gelsolin and cofilin activity (Nawaz et al., 2015; Zuchero et al., 2015). While these 
findings are consistent with our data, since increased NMII activity opposes actin protrusion, they 
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suggest that the inhibitory effect of ECM stiffness on OL maturation and differentiation would 
primarily be a factor during the early stages of OL differentiation, when OL branch and axonal 
contact is established. The effect of ECM stiffness on the movement of the inner myelin tongue 
would likely be minimal, because of the lack of direct contact between the ECM and the inner 
myelin membranes, as well as the fact that the movement of the inner tongue appears to be 
adhesion-independent (Nawaz et al., 2015). 
Mechanisms of OL mechanotransduction 
In an attempt to elucidate the mechanisms responsible for the effects we observed in OL, 
we have examined a number of transcription factors and regulatory pathways which play key roles 
in OL differentiation or NMII-dependent mechanotransduction. One of these was Olig1, a 
transcription factor essential for OL development and maturation which is present in the OL 
nucleus early during OL development, but must be phosphorylated and undergo a transition to the 
cytoplasm during differentiation (Niu et al., 2012), as nuclear Olig1 overexpression greatly reduces 
the spread of MBP-positive OL membrane. We found that in OL cultured on rigid matrices, Olig1 
is retained in the nucleus at nearly twice the level found in OL grown on compliant substrates. 
This suggests that the reduced OL complexity and significantly lower numbers of OL with MBP 
positive processes we observed in cultures grown on stiffer matrices are a result of mislocalization 
of Olig1 caused by an increase in ECM stiffness.  
YAP/TAZ are transcriptional cofactors in the Hippo regulatory pathway, which have been 
shown to play an essential role in matrix elasticity dependent mechanosensing that requires RhoA 
and NMII activity (Dupont et al., 2011). Soft ECM causes YAP/TAZ to accumulate in the 
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cytoplasm where it can be targeted for degradation, while rigid ECM promotes nuclear localization 
and activation of target genes. Consistent with this, nuclear levels of YAP were increased in OL 
cultured on rigid substrates, and reduced on compliant ones, demonstrating that an essential, NMII-
dependent mechanosensing pathway is engaged in the process of ECM-regulated OPC 
differentiation.  
In addition to YAP/TAZ, nuclear lamins have also recently been implicated as 
mechanosensitive molecules involved in transcriptional regulation. As integral components of the 
“nucleoskeleton”, they regulate changes in nuclear shape and are involved in maintaining 
chromatin organization (Puckelwartz et al., 2011) (Dechat et al., 2008). Increased nuclear lamin A 
levels are observed in cells grown on rigid matrices, while lamin B is more predominant on soft 
substrates or in soft tissues, and have been shown to direct the fate specification of mesenchymal 
stem cells (Swift et al., 2013).We found that in OL cultured on stiff matrices, the ratio of lamin A 
to lamin B was increased, as expected in cells grown on a rigid matrix, suggesting that nuclear 
lamins may be involved in the ECM-mediated regulation of OL morphology and differentiation. 
This is an especially interesting finding in light of the fact that lamin B overexpression resulting 
from gene duplication is the cause of adult-onset autosomal dominant leukodystrophy (Padiath et 
al., 2006) (Lin et al., 2014). Lamin B overexpression was also experimentally shown to cause 
defects in lipid and cholesterol synthesis (Rolyan et al., 2015), which is of potential interest 
because of cholesterol’s importance in maintaining the fluidity and elasticity of the cell membrane. 
While we have yet to identify a direct mechanistic link between ECM properties and OL 
differentiation, the data thus far suggest avenues for future work. Olig1 nuclear-cytoplasmic 
translocation is regulated by phosphorylation on serine 138, which is located within a well 
conserved protein kinase A (PKA) phosphorylation motif (Niu et al., 2012). These proposed PKA-
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mediated effects on Olig1 localization are consistent with the fact that OPC differentiation is 
promoted by cAMP and that a number of studies have shown the involvement of cAMP, PKA and 
cyclic AMP-response element binding protein (CREB) in promoting OPC differentiation and OL 
myelination (Baron et al., 1998) (Afshari et al., 2001) (Syed et al., 2013). Interestingly, PKA has 
also been shown to inhibit RhoA, which in turn indirectly promotes the inhibitory phosphorylation 
of YAP/TAZ, leading to their translocation from the nucleus to the cytoplasm (Yu et al., 2013). 
(Figure 1.4) 
This suggests that PKA activity can potentially drive increased Olig1 cytoplasmic 
localization, cytoplasmic translocation and degradation of YAP/TAZ, as well as inhibition of 
RhoA and downregulation of NMII activity, accounting for the majority of the effects we have 
observed as a consequence of culturing OL on soft matrices and promoting OL differentiation. 
However, while mechanical forces have been shown to, for example, activate PKA/CREB 
signaling in cardiac fibroblasts (Husse and Isenberg, 2010) or induce chondrocyte differentiation 
in a PKA dependent manner (Juhasz et al., 2014), there is currently no evidence that PKA activity 
is regulated by mechanical cues in oligodendroglia, leaving it open to investigation.  
Another possible modulator of YAP/TAZ localization is GPCR activity. A number of G 
protein subunits have been shown to regulate YAP/TAZ phosphorylation, with G12/G13 α subunits 
strongly inhibiting LATS kinases and therefor reducing YAP/TAZ phosphorylation, and Gαs 
exerting the opposite effect (Yu et al., 2012). Moreover, the PKA-dependent regulation of 
YAP/TAZ described above occurs downstream of cAMP signaling that is driven by Gαs activity, 
and opposes G12/G13 mediated RhoA activation (Yu et al., 2013). These findings are particularly 
interesting in light of that fact that an adhesion GPCR, GPR56, has been shown to regulate 
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myelination by promoting OPC proliferation, and may do so in a G12/G13 and RhoA dependent 
manner (Ackerman et al., 2015). 
Mechanical forces alone fail to regulate SC differentiation 
NMII contractility plays an important role in SC myelination – its downregulation by the 
knockdown of MLC causes SC to aberrantly extend multiple processes, and prevents them from 
efficiently myelinating axons in DRG/SC co-cultures (Wang et al., 2008). This dependence on 
NMII activity suggested that SC were likely to be sensitive to mechanical cues, most likely 
originating from the dense ECM they inhabit. However, while this proved to be the case, the 
overall impact of ECM rigidity on SC morphology was initially much less notable compared to 
what we observed previously in OL. 
SC which were not treated with cAMP and grown on soft collagen-coated matrices did 
exhibit a higher degree of elongation, increased numbers of actin-based protrusions and lower 
levels of MLC phosphorylation compared to those cultured on rigid matrices, in a manner 
consistent with the established effects of soft ECM on cell morphology and consistent with the 
effects we have previously observed as a result of NMII inhibition in SC. However, when 
differentiation was induced with cAMP treatment, most morphological differences were greatly 
diminished.  
Similarly, while matrix stiffness proved to influence the expression of key regulators of SC 
differentiation, the differences were not strongly pronounced. While SC cultured on soft matrices 
without cAMP exhibited lower levels of phosphorylated MLC and phosphorylated focal adhesion 
kinase (FAK), as well as increased levels of the negative regulator of myelination c-Jun, the 
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elevation of c-Jun on soft ECM was slight, and the differences were completely abolished 
following the addition of cAMP.  Likewise, while the expression of positive regulators of 
myelination Oct-6 and Krox20 was somewhat increased in differentiating SC grown on stiff 
matrices, the difference in Oct-6 was very slight, and the raise in Krox20 level was not statistically 
significant.  This suggests that while matrix stiffness alone does affect SC morphology and 
transcription factor expression, the effect is very modest when compared to those brought about 
by cAMP signaling (Morgan et al., 1991) (Monje et al., 2010). 
SC mechanotransduction requires ECM laminin 
Schwann cells are radially polarized, in that they have an inner, adaxonal membrane which 
interacts with the axolemma, and an outer abaxonal surface which contacts the basal lamina 
(Salzer, 2003).  SC begin to secrete the basal lamina after axonal envelopment (Clark and Bunge, 
1989).  It is their only direct source of ECM contact and the proteins which comprise it, laminin-
211 and 411 in particular, play an important role in normal myelination (Nakagawa et al., 2001; 
Wallquist et al., 2005).  The basal lamina secreted by immature SC is thin and incomplete, but 
becomes increasingly dense as myelination progresses (Cornbrooks et al., 1983), and Focal 
Adhesion Kinase (FAK) activity, which promotes cell adhesion and spreading, is necessary to 
compensate for the limited integrin engagement offered by the immature lamina (Grove and 
Brophy, 2014).   
Since our initial experiments used collagen-coated substrates, their results reflected the 
effects of changes in ECM rigidity, but not the changes in composition of the basal lamina 
occurring during SC differentiation and myelination. To increase the physiological relevance of 
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our model system, we incorporated varying levels of laminin into our ECM-like substrates. We 
found that SC differentiation in response to cAMP, as measured by Krox20 expression, was 
significantly enhanced in cells growing on the rigid matrices at the high laminin concentration 
representing the mature basal lamina.  
This finding was particularly interesting in view of the recently described laminin-211 
dependence of GPR126, an adhesion G-protein coupled receptor required for mammalian PNS 
myelination (Monk et al., 2011). GPR126 consists of two primary domains: a transmembrane C-
terminal fragment (CTF) which promotes SC differentiation and wrapping of axons by regulating 
cAMP levels through Gαs and Gαi signaling (Mogha et al., 2013), and an autoproteolytically 
cleaved extracellular N-terminal fragment (NTF) which interacts with laminin-211 and is 
necessary for the radial sorting of axons (Petersen et al., 2015). The NTF also associates with the 
CTF at the membrane, inhibiting CTF activity. This inhibitory interaction, which leads to a 
reduction in cAMP levels, can be stabilized by low levels of laminin, such as are present in an 
immature basal lamina. However, as laminin concentration and polymerization increase, the forces 
transmitted through the laminin fibers dissociate the NTF from the CTF, relieving the inhibitory 
effect. This mechanism is fully consistent with the effects we observed, in that Krox20 levels are 
at their highest in cells which are exposed to both high concentrations of laminin and high matrix 
rigidity.  
Intriguingly, laminin-211 has also been implicated as a negative regulator of myelination. 
The work of (Heller et al., 2014) demonstrates the convergence of two opposing regulatory 
pathways on to PI 3-kinase, which is known to be a critical factor in the initiation of myelination 
(Maurel and Salzer, 2000). The first, which is mediated by axonal neuregulin-1 type III is pro-
myelinating, while the second, involving α6β4 integrin and laminin-211 is inhibitory and prevents 
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hypermyelination. However, these apparently paradoxical effects of laminin-211 are not 
contradictory, since there is data showing that laminin-211 / GPR126 / cAMP signaling, while 
necessary for the initiation of myelination in conjunction with neuregulin-1 type III signaling, is 
not required for long-term myelin maintenance (Glenn and Talbot, 2013).  
This increasing evidence showing the importance of integration of various converging 
adaxonal and abaxonal signals also helps to place in context our laboratory’s earlier findings 
(Leitman et al., 2011) that while NMII inhibition via MLCK knockdown in SC in vitro promotes 
the expression of Krox20 and myelin proteins, the cells are unable to wrap and produce compact 
myelin when exposed to axons. This led us to propose a biphasic model of SC dependence on 
NMII activity, in which NMII inhibition caused by axonal signaling promotes differentiation, but 
this is not sufficient for myelination in the absence of NMII activity-promoting interactions 
between integrins and the abaxonal basal lamina. 
ECM-dependent approaches to PNS regeneration 
The role of ECM-derived signaling in SC differentiation can be particularly important 
given current research into surgical PNS repair, in which nerve engraftment is a common 
technique. Due to limited availability of donor tissue, a great deal of research has been directed at 
developing engineered alternatives, using a staggering array of materials, ranging from natural 
ones based on collagen, fibrin or chitosan, to synthetic ones fabricated from silicone, poly(lactic-
co-glycolic acid) (PLGA) or poly(caprolactone fumarate) (PCLF) (Daly et al., 2013; Gerth et al., 
2015). There have also been numerous attempts to improve their performance, ranging from 
relatively simple micro-patterning of the grafts to encourage growth and migration, to highly 
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elaborate ones like seeding them with Schwann cells engineered to over-express neurotrophic 
factors (Meyer et al., 2015). 
However, to our knowledge, there have been no attempts to examine how the mechanical 
properties of either biomaterial grafts or of the healthy PNS ECM affect the morphology and 
differentiation of Schwann cells. Since there is evidence that in engineered tissues mechanical 
forces play a role in promoting cell and ECM organization conducive to nerve repair (Georgiou et 
al., 2013), and that mechanical stimulation has been shown to promote nerve repair and 
remyelination (Kim et al., 2013), examining how SC differentiation is affected by mechanical 
forces can have important implications for developing strategies for peripheral nerve regeneration. 
Concluding remarks 
The developmental niches inhabited by oligodendrocytes (OL) and Schwann cells (SC) 
vary significantly in their mechanical properties. In the central nervous system (CNS), the 
extracellular matrix (ECM) is diffuse and highly elastic compared to that of the peripheral nervous 
system (PNS), which consists of much denser nerve bundles in which SC secrete their own basal 
lamina. ECM plasticity is capable of regulating cell morphology and gene expression in a process 
known as mechanotransduction, which depends on the regulation of cytoskeletal tension by NMII 
activity, and our work shows that both OL and SC are capable of responding to changes in ECM 
properties. While low matrix stiffness promotes OL morphological maturation and expression of 
markers of myelination, SC differentiation is upregulated by increased matrix rigidity in a process 
that requires the presence of ECM laminin. (Figure 4.1) These findings enhance the understanding 
of the basic cellular mechanisms of myelination. Additionally, since ECM mechanical properties 
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in both the PNS and CNS can vary following disease and injury, studying how these mechanical 
factors regulate OL and SC development may be important for optimizing therapies designed to 
promote nerve regeneration and remyelination. 
Figure 4.1 Revised model of ECM regulation of glial cell differentiation. 
The mechanical properties of the ECM are capable of regulating the morphology of both 
oligodendrocytes (OL) and Schwann cells (SC). In OL, increased ECM stiffness leads to an 
increase in myosin activity, inhibiting both OL branching and expression of differentiation 
markers. Conversely, increases in ECM rigidity can promote SC differentiation, but this effect is 
greatly potentiated by increased levels of ECM laminin. 
60 
Chapter 5: Materials and Methods 
Preparation of glial cultures on ECM protein substrates of varying elasticity 
Thin polyacrylamide substrates (PA) of different viscoelastic moduli were prepared as 
previously described (Tse and Engler, 2010) (Fischer et al., 2009). Briefly; NaOH-cleaned 12 mm 
glass coverslips were coated with 0.5% 3-aminoproyltrimethoxysilane in diH2O for 10 minutes at 
RT, rinsed extensively, incubated with 0.5% glutaraldehyde in PBS for 30 min at RT, rinsed for 
30 min under running diH2O, and allowed to air-dry in a laminar flow hood. Glass slides were 
coated with a thin layer of Rain-X (ITW Global Brands), allowed to dry, wiped with 100% ethanol, 
rinsed under running water for ~10 min and allowed to dry as above. PA solutions ranging from 
7.5 acrylamide/ 0.05% bis (Young’s modulus E~ 1.5 kPa) to 12% acrylamide/ 0.28% bis (Young’s 
modulus E~30 kPa) prepared in PBS and activated with 10% ammonium persulfate and TEMED 
(3µl of 10% APS and 2 µl TEMED per 500µl of PA solution). The activated solutions were 
immediately pipetted on to the Rain-X treated slides, covered with the treated 12mm cover slips 
(6 µl of PA solution per 12mm cover slip) and allowed to polymerize for 10 min at RT. After 
polymerization, the slides and cover slips were placed in PBS solution, and a razor was used to 
gently dislodge the PA-coated 12mm cover slips from the Rain-X treated slides. The substrates 
were placed in 24-well plates in PBS, rinsed, allowed to sit at 4oC overnight with gentle shaking 
to allow any unpolymerized PA to diffuse out, then washed 3 times with PBS.  To make a sandwich 
gel, PA gels were activated for crosslinking with 365 nm UV light using Sulfo-SANPAH (Pierce) 
and incubated with ECM protein (0.1mg/ml Collagen I or 0.1 mg/ml Collagen I plus 5-20 µg/ml 
mouse laminin-111 for PNS cultures; 20μg/ml matrigel for CNS cultures) overnight at 37oC. After 
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extensive washing, primary glial cells (3-5x104 for IF or 1x105 for WB) were plated on top of the 
cross-linked substrates and allowed to adhere overnight. 
Atomic force microscopy (AFM) 
The elastic modulus of soft and stiff PA gels was measured by AFM nano-indentation and 
confirmed to match the predicted values (Table 2.1). Briefly, an Asylum Research MFP-3D-BIO 
Atomic Force Microscope was used to collect force curves and force maps of the two groups of 
gels.  A CP CONT-PS C (NanoAndMore.com) probe with a 6.1 μm polystyrene bead was used 
for the spherical Hertz model indentations, and an Olympus TR400PB Long Cantilever 
(AsylumResearch.com) was used for the pyramidal Hertz model indentations.  The Asylum 
Research GetReal calibration method was utilized for calibration of the spring constant.  We have 
independently verified that the GetReal calibration gives adequate calibrations when compare 
directly to the thermal tune method for these probes. The same probe was used for all 
measurements amongst and between groups, and the groups were rotated between measurements.  
Force maps were conducted in PBS.  Curves were collected to a trigger point of 100 nN for 
spherical indenters and 25 nN for pyramidal indenters.  A 1 second dwell was incorporated into 
the force curve to elucidate viscous behavior.  A 50 µm/s indentation velocity was employed 
because we found the gels to have a high rate of creep, with slower velocities causing the gel to 
yield to the bead and preventing clean force curves from being collected.  The curves were fit with 
the Hertz model as utilized in the Asylum Research software.  Each force map samples a grid 
across a 90 um x 90 um area.  We sampled 4 gels from each group with the spherical indenter, and 
each gel was sampled 3 times, producing a total of 12 force maps consisting of 256 curves per 
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sample, or a total of 3072 measurements for each type of gel.  For tissue measurements, fresh brain 
and nerves (teased vs. unteased fibers) were compared, as well as spherical vs. pyramidal indenters. 
Glial cell purification 
A2B5+ oligodendrocyte precursors (OPC) were purified by immunopanning (negative 
Ran2 panning, positive A2B5 panning) from mixed glial cultures of postnatal day 2 rat cerebral 
cortices as previously described (Wang et al., 2008). Purified OPC were seeded on to PA/ECM 
elastic substrates in 24-well plates and maintained in either proliferation media with PDGF (10 
ng/ml) and bFGF (10 ng/ml), or induced to differentiate in media containing T3 (30 ng/ml). For 
inhibition studies, Y267632 (Calbiochem) was added to the media (10 µm) and maintained 
throughout the experiment (1-3 days).  
Mouse OL were prepared as previously described (O'Meara et al., 2011). Briefly, mixed 
glial cultures were prepared from postnatal day 2 mouse cerebral cortices of PlpCre/ESR1:Rosa26-
mT/mG:NMII fl/fl and PlpCre/ESR1:Rosa26-mT/mG:NMIIB+/+ animals (Rusielewicz et al., 2014), 
and used to generate OL-enriched glial cultures by separating the OL from the astrocyte monolayer 
by orbital shaking, followed by purification by differential adhesion to plastic. Purified OPC were 
seeded on to PA/ECM elastic substrates. Recombination was induced with 1 µM tamoxifen and 
the cells were allowed to differentiate for 48-72 hours in medium containing T3 (30 ng/ml).  
Schwann cells (SC) were isolated from postnatal day 2 rat sciatic nerves and expanded for 
3 weeks in M media (MEM, 10% FBS and 2 mM L-glutamine), supplemented with 4 µM forskolin 
(Sigma), and 5 ng/ml of the EGF domain of rhNRG-1-β1 (R&D Systems), hereafter called M+ 
media. For studies on the effects of cAMP analogues on SC differentiation, cultures maintained in 
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M+ media were switched to media without growth factors for 3 d (M media). SC were either starved 
overnight in serum-free M media (MEM and 2 mM L-glutamine), or placed in defined media DM 
(DMEM/F12, 5 µg/ml insulin, 5 µg/ml transferrin), prior to treatment with 1 mM dibutyryl cyclic 
adenosine monophosphate (db-cAMP) (Calbiochem), for 24h ,48h and 72h. 
Immunofluorescence 
Glial cell cultures on PA/ECM substrates were fixed in 4% PFA for 10 minutes and 
processed for immunocytochemistry as previously described (Wang et al., 2008). Briefly, cells 
were permeabilized for 5 minutes with 0.5% Triton X-100 and blocked with 5% BSA, 2% donkey 
serum and 0.2% Triton X-100 for 1 hour at room temperature. This was followed by an overnight 
incubation with primary antibodies in blocking solution at 4oC, and a 1 hour room temperature 
incubation with secondary antibodies in blocking solution. The stained cultures were mounted 
using ProLong Gold anti-fade reagent, and imaged by epifluorescence using a Leica DMI4000 
microscope with LAS 1.7.0 software equipped with a digital camera (DFC350FX; Leica) and the 
following objectives: N PLAN 10 × /0.25 NA; N PLAN L40 × /0.55 NA; and HCX PL APO CS63 
× /1.4 NA oil UV (all from Leica). Image analysis (see below) was performed using ImageJ. 
Image analysis 
OPC were counted in micrographs from 10-12 random 20X fields/coverslip, using ImageJ 
(total of 20-30 fields per condition per experiment; total of 2-3 experiments). For the evaluation of 
morphology, OPC were counted and classified according to their branching complexity as follows: 
(0): no branching; (1) low complexity: cells with at least one or two branches directly from cell 
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body; (2) medium complexity: cells with secondary processes extending from primary branches 
and (3) high complexity: cells with tertiary processes extending from secondary branches.  
The shape of Schwann cells was quantified by manually tracing individual cells using the 
ImageJ polygon selection tool, and using the ImageJ measure tool to determine their aspect ratio 
and solidity (Analyze > Set Measurements > Shape Descriptors). Aspect ratio is a measure of the 
extent of cellular polarization and is defined as the ratio of length (major axis) to width (minor 
axis) of a best-fit ellipse derived from the cell. Solidity corresponds to cell convexity, and is 
derived by dividing the traced area of the cell by the area of a convex hull applied to that cell 
(Carpenter et al., 2006). While aspect ratio corresponds to cell polarization, solidity is reflective 
of cell branching. Cells with a large number of processes would have low solidity while more 
polygonal cells would have higher solidity. 
For quantitation of nuclear fluorescence intensity, random 20X fields were captured from 
cultures co-stained with DAPI and phalloidin as well as immunostained for either c-Jun, Oct6, 
Krox-20 or Olig1. The DAPI channel was used to establish areas of interest corresponding to the 
nuclei by using the ImageJ nucleus counter tool with manual corrections. The ROIs established by 
the nucleus counter were added to the ROI manager, and then used, along with the ImageJ measure 
tool, to record the mean gray value of c-Jun, Oct6, Krox-20 or Olig1 staining within the nuclear 
regions. Background fluorescence was measured in the areas outside the nuclear ROIs, averaged, 
and subtracted from the mean nuclear gray value. Statistical tests (t-test and ANOVA) were 
performed using Graph Pad Prism software. 
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Cell extracts and Western blotting 
To prepare lysates, seeded PA/ECM culture substrates were transferred to new 24-well 
plates, washed gently with PBS, and treated with lysis buffer (95 mM sodium chloride, 25 mM 
Tris-HCl, 10 mM ethylenediaminetetraacetic acid, 2% sodium dodecylsulfate, pH 7.5, protease 
and phosphatase inhibitor cocktail). Protein concentration was assayed by BCA, equal protein 
amounts (5-10 μg) per condition were loaded and separated by SDS-PAGE and blotted onto 
nitrocellulose. Appropriate regions of the blots were cut and incubated with specific antibodies 
and developed using chemiluminescent substrate (Pierce). Nuclear and cytoplasmic fractions were 
prepared using the Active Motif Nuclear Extract Kit (AM 40010). Briefly, the cells were lysed 
using detergent treatment under hypotonic conditions and the nuclei separated by centrifugation at 
14,000g, followed by SDS-PAGE, as above. In order to quantify protein levels, films from 2-3 
independent experiments were scanned, and the absolute intensity of the protein bands of interest 
as well as the corresponding loading controls was measured using ImageJ (Analyze > Gels). The 
relative intensity of the protein bands was then calculated by dividing the absolute intensity value 
of the protein band by the absolute intensity of the loading control. Actin and tubulin were used as 
controls for whole cell lysates, and histone H3 as the control for the nuclear fractions.  
Antibodies 
Antibodies used in these studies included those reactive to: MBP (Covance SMI-94R), 
anti-Rip antigen supernatant (DS Hybridoma Bank), Olig1 (Millipore AB5540), M2B (Covance 
PRB-44P), MLC2 (Cell Signaling 3672S), phosphorylated MLC2 (Cell Signaling 3674S), P-(S/T) 
PKA substrate (Cell Signaling 2261S), YAP (Santa Cruz SC-271134), lamin A/C (Cell Signaling 
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4777S), Lamin B1 (Santa Cruz SC-20682), histone H3 (Cell Signaling 4499), c-Jun (BD 
Technologies 610326), Oct6 (GenWay 18-003-42328), Krox-20 (Covance PRB-236P), FAK (Cell 
Signaling 3285), pFAK (Cell Signaling 3281s) actin (Sigma A2066), tubulin (Epitomics 2871-1), 
Ki-67 (Millipore). Staining was also performed with phalloidin-FITC (Thermo A12379) Acti-
Stain 555 (Cytoskeleton PHDH1) and phalloidin Acti-Stain 670 (Cytoskeleton PHDN1). 
Secondary antibodies conjugated to rhodamine, fluorescein, coumarin, or cyanin 5 were obtained 
from Jackson Laboratories. 
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